Work

P3.04-003 Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC

Year: 2017

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.09.1661

Authors: H. Ross, D. Kozono, J. Urbanic, T. Williams, C. Dufrane, I. Bara, M. Gandhi, K. Schulze, J.M. Brockman, X. Wang, E. Vokes, T. Stinchcombe

Institutions: Mayo Clinic in Arizona, Dana-Farber Cancer Institute, University of California San Diego, The Ohio State University, Alliance Foundation Trials, Genentech, Duke Medical Center, University of Chicago, Duke University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2767459728

FWCI: 0.121

Cites:

Cited by: 1

Related to: 10